Pharmaceutical Technology

SEPTEMBER 14, 2022

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Contract marketing companies build a strong sales and marketing team rapidly and save efforts and time on the recruitment process.

Marketing 100

Marketing Contract Manufacturing Sales Clinical Trials 100

Pharmaceutical Technology

JULY 29, 2022

In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs). A nitrogen-binding drug, its global sales were $292m in 2021, as per GlobalData. Other treatments include sodium phenylbutyrate marketed as Buphenyl or Ammonaps.

RNA 245

RNA Gene Expression Gene Gene Therapy 245

Pharmaceutical Technology

SEPTEMBER 14, 2022

The growing demand for innovative drugs and a limited number of blockbuster drugs has led to the growth of the pharmaceutical contract manufacturing market, which has fuelled contract commercial dose manufacturing and marketing. Discover the leading commercial dose companies in contract marketing.

Marketing 100

Marketing Contract Manufacturing Manufacturing Containment 100

Fierce Pharma

OCTOBER 31, 2023

Even as Catalent dusts itself off from a pandemic sales plunge, the company may be teetering on the edge of another contract manufacturing precipice.

Gene Therapy 59

Gene Therapy Gene Contract Manufacturing Trials 59

BioPharma Reporter

AUGUST 21, 2023

Novartisâ board of directors has unanimously agreed to separate Sandoz as a 100 per cent spin-off with a $15 billion share buyback.

Sales 94

Sales Contract Manufacturing Manufacturing 94

The Pharma Data

APRIL 22, 2023

Novo Nordisk raises sales and operating profit outlook for 2023 Novo Nordisk today announced the sales and operating profit growth at constant exchange rates (CER) for the first three months of 2023 and that the full-year sales and operating profit outlook at CER has been raised.

Sales 40

Sales Contract Manufacturing Manufacturing Medicine 40

The Pharma Data

JULY 22, 2021

Beyond dental and through its Novocol Pharma division, the group also partners with pharmaceutical and medical device companies to provide contract manufacturing services for pharmaceutical products that require cartridge filling. The group counts 1,900 employees and has a long-established presence in more than 150 countries.

Branding 52

Branding Production Sales Contract Manufacturing 52

Pharmaceutical Technology

JUNE 6, 2023

Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services.

Contract Manufacturing 100

Contract Manufacturing Manufacturing Production Pharmacy 100

Pharmaceutical Technology

MAY 26, 2023

The acquisition targets had a wide variety of manufacturing services, including API and dose manufacturing, packaging, and analytical services. Although there is a slight dip in M&A activity in 2022 compared to 2021, it is still higher than levels in 2018–2020.

Life Science 130

Life Science Manufacturing Contract Manufacturing Gene Therapy 130

pharmaphorum

JULY 7, 2021

Three months ago, the FDA said it was unconvinced by a bridging study designed to show equivalence between Provention’s product intended for commercial sale, made by contract manufacturer AGC Biologics, and the drug that teplizumab’s original developer Eli Lilly used in clinical trials.

Drugs 98

Drugs Insulin Contract Manufacturing Antibody 98

pharmaphorum

FEBRUARY 8, 2022

Nevertheless, the decision by NICE to back routine NHS use of Wegovy is a win for Novo Nordisk, which has been hit by supply constraints linked to a contract manufacturer for the drug that have affect its rollout in the US, where it was approved last June.

Drugs 105

Drugs Contract Manufacturing Clinical Trials Clinical Trials 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. Manufacturing for Wegovy was also hit when a contract manufacturer in charge of syringe filling halted deliveries due to issues with good manufacturing practices.

Drugs 264

Drugs Manufacturing Hormones Clinical Trials 264

Drug Patent Watch

DECEMBER 10, 2024

The biosimilars market has been growing at an unprecedented rate, with global sales projected to reach over $60 billion by the end of the decade. This approach can help reduce the complexity and variability associated with biologic manufacturing, leading to more efficient and cost-effective processes.

Manufacturing 96

Manufacturing Drugs Production Contract Manufacturing 96

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. Manufacturing for Wegovy was also hit when a contract manufacturer in charge of syringe filling halted deliveries due to issues with good manufacturing practices.

Drugs 246

Drugs Manufacturing Hormones Clinical Trials 246

pharmaphorum

JANUARY 3, 2023

It’s first marketing application was turned down in October 2021 with an FDA request for more technical and manufacturing information focusing on the xenon hyperpolariser system. The post FDA clears Polarean’s lung disease diagnostic Xenoview appeared first on.

Contract Manufacturing 64

Contract Manufacturing Manufacturing FDA Approval Pharma Companies 64

pharmaphorum

NOVEMBER 2, 2020

Once formed, Viatris will be a generics behemoth with annual sales of around $19 to $20 billion and operations in 165 markets around the word. Upjohn is now due to be spun off from Pfizer on 13 November, with the merger concluding three days later – around 16 months after first being announced.

Generic Drugs 52

Generic Drugs Contract Manufacturing Production Manufacturing 52

pharmaphorum

MARCH 21, 2022

Prior to the FDA rejection , GlobalData was predicting global peak sales of $691 million for teplizumab in 2027. Now, the regulator has accepted the resubmission, kicking off another six-month review period as teplizumab has previously been awarded breakthrough status.

Drugs 52

Drugs Insulin Contract Manufacturing Clinical Trials 52

Roots Analysis

FEBRUARY 27, 2024

What are the financial terms of the agreement: Ambrx is likely to receive an undisclosed upfront payment, development milestones, and a double-digit royalty on product sales in China. NovoCodex is also eligible to share an undisclosed portion of ARX305 product sales outside of China. Check the details of the agreement here.

Antibody 40

Antibody Marketing Drugs Contract Manufacturing 40

pharmaphorum

NOVEMBER 18, 2022

The agency said at the time it was unconvinced by a bridging study designed to show equivalence between Provention’s product – made by contract manufacturer AGC Biologics – and the drug that teplizumab’s original developer Eli Lilly used in clinical trials.

Drugs 52

Drugs FDA Approval Insulin Clinical Trials 52

pharmaphorum

AUGUST 11, 2021

There has been a facility inspection carried out by the FDA at the contract manufacturer for the drug, but Axsome said it was unaware of any ‘Form 483’ issues – when inspectors see conditions they deem to be objectionable.

Drugs 52

Drugs Contract Manufacturing Marketing Clinical Trials 52

The Pharma Data

OCTOBER 12, 2021

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Boehringer Ingelheim.

Medicine 52

Medicine Contract Manufacturing Research Production 52

The Pharma Data

MARCH 22, 2022

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Boehringer Ingelheim. Source link: [link] /.

Research 52

Research Scientist Contract Manufacturing Medicine 52

The Pharma Data

JANUARY 5, 2021

Novasep’s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA , China and India. 6,200 people, and earned sales revenue of 1,440.6 million euros.

Manufacturing 40

Manufacturing Sales Contract Manufacturing Insulin 40

The Pharma Data

NOVEMBER 5, 2020

is a rapidly growing generic pharmaceutical company in the United States devoted to discovery, manufacture, sale, and distribution of prescription generic pharmaceutical products. About Jubilant Cadista Pharmaceuticals Inc. Jubilant Cadista Pharmaceuticals Inc. View original content to download multimedia: [link].

Marketing 40

Marketing Generic Pharmaceutical Contract Manufacturing Manufacturing 40

The Pharma Data

OCTOBER 27, 2020

SYNEO also provides world-class component processing and assembly services for catheter and guidewire applications utilizing its in-house production equipment and tooling.

Contract Manufacturing 40

Contract Manufacturing Manufacturing Life Science Production 40

The Pharma Data

MARCH 16, 2021

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros.

Development 52

Development Contract Manufacturing Licensing Licensing 52

The Pharma Data

MARCH 2, 2021

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros.

In-Vivo 52

In-Vivo Contract Manufacturing Bioinformatics Clinical Development 52

The Pharma Data

JANUARY 24, 2021

(TSXV: THRM) (“Therma Bright” or the “Company”), a progressive medical device technology company announces that it has taken 100% control of the research and development, regulatory, manufacturing and commercialization of its saliva-based rapid antigen test. The securities have not been registered under the U.S.

Sales 40

Sales Manufacturing Contract Manufacturing Containment 40

Fossil Remedies

JULY 18, 2019

The third-party manufacturing partner has a rich professional experience in the niche. It results in better sales and higher profits. Better work efficiency is guaranteed when you invest in a third-party manufacturing contract. It is a great benefit for you. It gives you quality products that you can rely upon.

Manufacturing 60

Manufacturing Pharma Companies Production Pharma Production 60

XTalks

JANUARY 23, 2024

This venture also led me to identify a gap in the market for contract manufacturing of recombinant proteins. Our strategy involves closely working with pediatric endocrinologists and a targeted sales force, potentially enabling us to efficiently cover markets like the US.

Development 72

Development Hormones Drugs Trials 72

The Pharma Data

SEPTEMBER 11, 2021

Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Source link: [link].

Antibody 52

Antibody DNA Containment Manufacturing 52

The Pharma Data

MARCH 20, 2021

According to the Demand Generation Benchmark Report, 2016, 47% of buyers viewed 3-5 pieces of content before engaging with a sales rep. Introduction: For a company to succeed in the ultra-competitive global biopharma landscape, it’s simply not enough to deliver exceptional products and services at a competitive price.

Development 52

Development Marketing Branding Contract Manufacturing 52

The Pharma Data

JANUARY 27, 2021

The following risks and uncertainties may cause our actual results, levels of activity, performance, or achievements to differ materially from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements: our ability to raise capital to fund our operations, including but not limited to, (..)

Clinical Trials 52

Clinical Trials Clinical Trials Production Trials 52

XTalks

JUNE 14, 2023

The online marketplace PartnerSlate has made waves in the food and beverage contract manufacturing industry, recently securing a $4 million investment to further its mission of connecting food brands and contract manufacturers. This is where San Francisco-based PartnerSlate comes in.

Contract Manufacturing 98

Contract Manufacturing Manufacturing Branding Packaging 98

The Pharma Data

JANUARY 27, 2021

For over a decade, the company and its team have been leaders in the design, testing and manufacture of thin film drug formulations, particularly transdermal patches and sub-lingual (oral) strips for the delivery of active pharmaceutical ingredients (“API”) for the treatment of pain and neurological conditions.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

Pharmaceutical Technology

APRIL 24, 2023

Mahesh Bhalgat, Syngene’s chief operating officer In the US, which has among the highest contract manufacturing rates globally, 140 contract manufacturing organizations have 207 facilities capable of producing active pharmaceutical ingredients (API) for protein and peptide-type biologics.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

The Pharma Data

JANUARY 5, 2021

In addition, Radius may pay sales-based milestone payments and a tiered, high single-digit effective royalty. based contract manufacturing business, Benuvia Manufacturing, which has significant chemistry and formulation capabilities, including manufacturing our FDA-approved cannabinoid drug, SYNDROS ® ,” said Todd C.

Manufacturing 52

Manufacturing FDA Approval Trials Development 52